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Can We Engineer Our Way to Good Health?
Russell T. Carr, Professor of Chemical Engineering

Abstract
Engineering technologies contribute to our health. Purification of drinking water has been of great benefit
to public health. Large-scale production of penicillin is another engineering triumph that improved our
health.
Medical imaging technology has come a long way since the X-ray. Ultrasound and MRIs are now commonplace. Can imaging technologies be used in new ways in our search for better health? Computer simulations promise greater understanding of physiologic processes in disease and health. Simulations require
quantitative mathematical models of physiology.
Digital wireless communications can be used to build a national medical database. The benefits of such
a database are great. What challenges must be overcome to make this a reality? The current identity-theft
problem indicates that security and privacy are significant hurdles.
Chemistry is now being miniaturized, much like electronics were 50 years ago. EMTs could use “lab-ona-chip” devices to get an “instantaneous diagnosis” from a drop of blood. Understanding of fluid behavior
and chemical reaction on the micro-scale is required to develop a working “lab-on-a-chip.”
The April 1999 issue of Scientific American gave a glimpse of how “tissue engineering” might help health
care. “Apligraf,” a tissue engineered skin product, is a shining success. Other efforts have been less successful. After more than 30 years, the search for a small-bore vascular prosthesis continues.
Unfortunately, the more technology we introduce into health care, the more expensive it becomes. Can
we make these technologies affordable?

E

ngineering has a long history of improving public health. One hundred years ago, chlorination
of drinking water started in the United States at
Jersey City, N.J. In the beginning of the past century,
local transportation was still by horses, even in the
cities. As a result, animal waste was a major disposal
problem and water-borne diseases such as cholera,
typhoid, dysentery, and hepatitis A were killing about
25 out of 100,000 people in the U.S. at the time. Today,
these diseases are virtually eliminated in America,
and this is largely due to the purification and distribution of clean drinking water. The use of filtration and
chlorine to halt the spread of water-borne diseases is
often considered the most significant public health advance in history. Chlorination works because chlorine
is a strong oxidizing agent, which “breaks” down the
cell walls of the bacteria in the water. Chlorine activity
continues while the water is in storage tanks and pipes
so that the bacteria cannot repopulate. Clean drinking
water continues to be a great need in many parts of the
developing world and the design and construction of
purification and distribution systems presents a major

undertaking. Even in “developed” countries, continued
vigilance on water purification is required. There was
a five-year epidemic of cholera in Latin America starting in 1991 largely because of reduced disinfection of
drinking water. This relaxed attitude toward drinking
water chlorination was partly due to U.S. reports about
disinfection by-products in treated water. Research in
water purification today includes the use of ozone and
ultraviolet radiation.1
Alexander Fleming discovered the antibiotic properties of penicillium notatum by accident in 1928. A stray
spore of penicillium n. accidentally landed in a Petri
dish that was prepared for a culture of Staphylococcus.
After incubation, he noticed the presence of mold colonies surrounded by a zone of growth inhibited staph.
To further explore the properties of this mold, he grew
penicillium n in a surface culture on a liquid medium.
After a week, the liquid under the growing mold colony,
which Fleming called penicillin, was harvested. The
introduction of penicillin as a therapeutic drug for
medical care on a large scale did not occur until the
middle 1940s. Fleming’s penicillin was extremely dilute,
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impure, and chemically unstable. In response to fire
bombings in England during World War II, a group of
Oxford University researchers improved the surfaceculture method to make enough penicillin for clinical
trials. The dramatic effects of penicillin on wound
healing convinced the Allies that the large-scale production of penicillin would save the lives of thousands
of servicemen. Chemical engineers, microbiologists,
chemists, and biologists from universities, government, and industry set out to mass produce penicillin.
They searched for new strains of the mold and created
mutant strains with ultraviolet light. They discovered
better culture media. They invented a new purification processes. Even freeze drying was explored as
a means to stabilize the antibiotic. Perhaps the most
important development was the shift from surface
culture of the mold to submerged fermentation in huge
tanks. Problems in heat and mass transfer and careful
control of the environment inside the tanks needed
to be solved. By 1944, 100,000 unit vials of penicillin were coming off the end of the line at the Pfizer
plant faster than they could be counted. The American
Institute of Chemical Engineers considered the largescale production of penicillin to be one of the greatest
chemical engineering achievements of the century. The
development and production of therapeutic chemicals
is important in chemical engineering today as bioengineering represents a growth area.2
Imaging technology has come a long way from the
X-ray. The ability to “see” what is happening inside
the body can guide the diagnosis and effect the treatment of illness. Signal processing and the graphical
representation of information in a visual format have
led to novel ways of producing medically useful images. Computed tomography (CT scans) take a series
of X-ray images and computationally reconstructs a
3D image. When my first child was born three decades
ago, ultrasound imaging was fairly new. Now it is quite
common. In my own family, ultrasound imaging has
been used for prenatal care in pregnancy, amniocentesis, and echocardiograms. Magnetic resonance imaging provides greater contrast between “soft” tissues
than X-rays and has found widespread use in medicine
exploring brain, heart muscle, and cancer tissues. Infrared signals might be useful to detect breast cancer
at a very early stage based on differences in the amount
heat generated in cancer cells as opposed to normal
tissue.3 Image signal processing and “machine vision”
might be useful for examining light microscope slides
for detecting differences between normal and diseased
cells. Can image processing and computer simulations

be used to create “medical simulators” like those used
in the training of airplane pilots?
Computer simulations require quantitative mathematical models of physiological processes. My own
experimental research has focused on peculiarities of
blood flow in small vessels that are incorporated into
computer simulations of blood flow in microvascular
networks. These types of simulations are used to answer
questions about hypertension, vessel remodeling, and
drug delivery among others. The use of mathematics to
describe physiological phenomena has the potential to
quickly advance our understanding of both normal and
pathological physiology.4
When faced with an unusual or interesting clinical
case, sharing information with other physicians can
be invaluable to a doctor. In teaching hospitals, Grand
Rounds is a formal meeting where doctors discuss current or interesting cases. Patients then receive input
from several experienced medical personnel. This also
increases the experience base of the doctors. Modern
communications technology makes the sharing of information between doctors much easier. Today heart patients with an implanted cardio defibrillator can transmit information from the implant over the telephone to
their doctor. This is a step in providing real-time medical monitoring of the patient to the health professional.5
Suppose EMTs could have access to information about
prescription, allergies, etc. for victims when responding to emergencies. This could be done with a national
medical database. What are the challenges of such an
enterprise? Who is responsible for input of data? Who
can have access to it? Who maintains the database once
it is functioning? Can we protect patients’ privacy?
Technologically, it appears feasible, but several social
questions need answers.
Imagine instantaneous diagnosis from a drop of
blood when the EMT arrives in response to a 911 call.
This is known as point-of-care testing and is one of the
dreams driving the development of a “lab-on-a-chip.”
This is a Micro Mechanical Electric Systems, MEMS,
device into which a drop of blood flows through a
series of small channels, tens of microns in diameter,
and chemical reactions are monitored to diagnose the
condition of the patient. Such a device requires the understanding of micro-nano– manufacturing, fluid flow
in very small channels (microfluidics), and chemical
reaction at the micro scale. Although applications are
limited today, great potential exists for the contribution
of MEMS to health care delivery.6
Tissue engineering concerns the use of living cells to
improve health. Can we engineer replacement tissues
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for humans? The possibility is suggested by the discovery of stem cells and growth factors and the idea of cell
differentiation. One of the first growth factors, BMP
(bone morphogenetic protein), spontaneously induced
the growth of new bony tissue when placed in animals.
Not surprisingly, bone and cartilage are two of the first
applications of tissue engineering with therapeutic
value. The most successful tissue engineered product
is human skin equivalent by Organogenesis. This is
a product made from two layers of cells in collagen.
This product promotes healing for persistent wounds
and promoted the migration of host skin cells into the
wound to replace the transplanted cells. Other attempts
at tissue engineering have not been as successful. After
more than thirty years of effort, the search continues
for a small bore artificial blood vessel, as well as for
cellular-based therapies for liver, pancreas, and heart
disease.8
The technical possibilities of engineering our way to
good health are fascinating. There are many problems
to overcome and the journey should be exciting. A final
question, however, does need to be considered. Can
engineering technology make health care more affordable? In many endeavors, the introduction of more and
more technology has made things more affordable. The
tremendous research efforts in agriculture have resulted
in very affordable food crops in the U.S. Communications, transportation, and housing are more affordable
because of the use of technology. Is the same true for
health care? The inclusion of innovative technologies
into health care delivery has been cited as a major driver
of the increase in the cost of health care. Certainly,
health care costs have risen with the inclusion of more
innovation, but availability of services has also grown.9
Finally, can we engineer our way to good health in a
manner that we can afford?

Notes:

1. The faculty involved with the Water Treatment
Technology Center are very active in projects to maintain
our access to healthy drinking water. Professors Ballestero,
Collins, Jacobs, Kinner, and Malley of the Civil Engineering
Department are very active in this research. One of the
Environmental Engineering courses (ENE 740) is entitled
Public Health Engineering.
2. For a fascinating history of the development of penicillin
in the 1940s see Chemical Engineering Progress Symposium
Series Vol 66 No. 100 (Eng TP 1.A62 No.100). PT Vasudevan,
chair of the Chemical Engineering Department, teaches
a Biochemical Engineering course at UNH (ChE 761) and
many of our graduates work in the biopharmaceutical industry. Professor Vasudevan does important research in the area
of enzyme kinetics and has developed a rapid assay for total
blood cholesterol measurement.
3. Processing and interpretation of signals interacting with
biological systems is taught in Biomedical Instrumentation
ECE 784. CT scanners were invented at EMI (Electric and
Music Industries Ltd) in England. It is often said that the
funding for this project came from the success of their music recording business (Beatles, Beach Boys, etc.). Richard
Messner of the Electrical and Computer Engineering
Department is an expert on video image signal process and
pattern recognition and has made attempts to automate the
visual screening of malignant cells from Alzheimer’s patients. F. William Hersman, Physics Department, polarizes
Xenon to enhance MRI images of the lung.
4. See, for example, Annals of Biomedical Engineering vol.
33 pp 764-771, 2005. Greg Chini, Mechanical Engineering
Department, has done recent work on particle deposition
and impingement on thin liquid films in the lung.
5. Real-time monitoring of health parameters (vital signs)
provides a measure of both wellness (normal state) and the
onset of illness. The following video segment on the Internet
may be interesting. http://spie.org/documents/newsroom/
videos/HaroldSzu.mov
6. Nivedita Gupta, Chemical Engineering Department, has
started a new course on Microfluidics ChE 722. The Material
Science Program and the Chemistry Department participate
in the Center for High-rate Nano-manufacturing, which is
involved with MEMS devices.
7. Scientific American April 1999 issue starting on page 59.
An interesting note: Gary Bowlin, graduate of the Chemical
Engineering Department, is very active in tissue engineering research at the Biomedical Engineering Department of
Virginia Commonwealth University. http://www.egr.vcu.
edu/FacultyDetail.aspx?facid=5
8. An interesting view of the price of penicillin is included
in the Chemical Engineering Progress Symposium Series vol.
66 No. 100 pp 20-21 mentioned earlier. Also see Annals of
Internal Medicine 142:932-937, 2005 “High and Rising Health
Care Costs. Part 2: Technological Innovation” for a recent
analysis of technology-related health care costs.

